National Multiple Sclerosis Society   Report issue

Founded: New York NY United States (1946)

Organization Overview

First Clinical Trial
2002
NCT00405353
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

National Multiple Sclerosis Society